- Home
- PRAX vs KRP Comparison
PRAX vs KRP Comparison
Compare PRAX & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- KRP
- Stock Information
- Founded
- PRAX 2015
- KRP 2013
- Country
- PRAX United States
- KRP United States
- Employees
- PRAX N/A
- KRP N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- KRP Oil & Gas Production
- Sector
- PRAX Health Care
- KRP Energy
- Exchange
- PRAX Nasdaq
- KRP Nasdaq
- Market Cap
- PRAX 1.5B
- KRP 1.3B
- IPO Year
- PRAX 2020
- KRP 2017
- Fundamental
- Price
- PRAX $71.55
- KRP $15.59
- Analyst Decision
- PRAX Strong Buy
- KRP Buy
- Analyst Count
- PRAX 9
- KRP 4
- Target Price
- PRAX $146.33
- KRP $19.25
- AVG Volume (30 Days)
- PRAX 315.5K
- KRP 531.0K
- Earning Date
- PRAX 11-06-2024
- KRP 11-07-2024
- Dividend Yield
- PRAX N/A
- KRP 11.25%
- EPS Growth
- PRAX N/A
- KRP N/A
- EPS
- PRAX N/A
- KRP 0.52
- Revenue
- PRAX $1,605,000.00
- KRP $325,011,605.00
- Revenue This Year
- PRAX N/A
- KRP $17.78
- Revenue Next Year
- PRAX N/A
- KRP $2.97
- P/E Ratio
- PRAX N/A
- KRP $29.98
- Revenue Growth
- PRAX N/A
- KRP 30.47
- 52 Week Low
- PRAX $16.08
- KRP $14.26
- 52 Week High
- PRAX $86.93
- KRP $17.07
- Technical
- Relative Strength Index (RSI)
- PRAX 50.90
- KRP 42.40
- Support Level
- PRAX $70.03
- KRP $15.37
- Resistance Level
- PRAX $73.49
- KRP $16.11
- Average True Range (ATR)
- PRAX 4.10
- KRP 0.24
- MACD
- PRAX -0.17
- KRP -0.02
- Stochastic Oscillator
- PRAX 48.89
- KRP 38.95
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About KRP Kimbell Royalty Partners Common Units Representing Limited Partner Interests
Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas, and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.